Department of Psychiatry, A. J. Ernststraat 1187, 1081 HL, Amsterdam, The Netherlands
J Clin Psychiatry. 2014 Feb;75(2):119-26. doi: 10.4088/JCP.12m08047.
To examine the predictive role of insomnia and sleep duration on the 2-year course of depressive and anxiety disorders.
This study is a secondary data analysis based on data from the baseline (2004-2007) and 2-year assessment of the Netherlands Study of Depression and Anxiety. Participants were 1,069 individuals with DSM-IV-based depressive and/or anxiety disorders at baseline. Sleep measures included insomnia (Women's Health Initiative Insomnia Rating Scale score ≥ 9) and sleep duration (categorized as short [≤ 6 hours], normal [7-9 hours], or long [≥ 10 hours]). Outcome measures were persistence of DSM-IV depressive and anxiety disorders (current diagnosis at 2-year follow-up), time to remission, and clinical course trajectory of symptoms (early sustained remission, late remission/recurrence, and chronic course). Logistic regression analyses were adjusted for sociodemographic characteristics and chronic medical disorders, psychotropic medications, and severity of depressive and anxiety symptoms.
The effect of insomnia on persistence of depressive and/or anxiety disorders (OR = 1.50; 95% CI, 1.16-1.94) was explained by severity of baseline depressive/anxiety symptoms (adjusted OR with severity = 1.04; 95% CI, 0.79-1.37). Long sleep duration was independently associated with persistence of depression/anxiety even after adjusting for severity of psychiatric symptoms (OR = 2.52; 95% CI, 1.27-4.99). For short sleep duration, the independent association with persistence of combined depression/anxiety showed a trend toward significance (OR = 1.32; 95% CI, 0.98-1.78), and a significant association for the persistence of depressive disorders (OR = 1.49; 95% CI, 1.11-2.00). Both short and long sleep duration were independently associated with a chronic course trajectory (short sleep: OR = 1.50; 95% CI, 1.04-2.16; long sleep: OR = 2.91, 95% CI, 1.22-6.93).
Both short and long sleep duration-but not insomnia-are important predictors of a chronic course, independent of symptom severity. It is to be determined whether treating these sleep conditions results in more favorable outcomes of depression and anxiety.
探讨失眠和睡眠时间对抑郁和焦虑障碍 2 年病程的预测作用。
本研究基于荷兰抑郁和焦虑研究的基线(2004-2007 年)和 2 年评估的数据进行二次数据分析。参与者为基线时患有基于 DSM-IV 的抑郁和/或焦虑障碍的 1069 人。睡眠测量包括失眠(女性健康倡议失眠评定量表评分≥9)和睡眠时间(分为短[≤6 小时]、正常[7-9 小时]或长[≥10 小时])。结局测量包括 DSM-IV 抑郁和焦虑障碍的持续存在(2 年随访时的当前诊断)、缓解时间和症状的临床病程轨迹(早期持续缓解、晚期缓解/复发和慢性病程)。逻辑回归分析调整了社会人口统计学特征和慢性内科疾病、精神药物以及抑郁和焦虑症状的严重程度。
失眠对抑郁和/或焦虑障碍持续存在的影响(OR=1.50;95%CI,1.16-1.94)可通过基线时抑郁/焦虑症状的严重程度来解释(调整后的严重程度 OR=1.04;95%CI,0.79-1.37)。长睡眠时间与抑郁和焦虑的持续存在独立相关,即使在调整了精神症状严重程度后也是如此(OR=2.52;95%CI,1.27-4.99)。对于短睡眠时间,与合并抑郁/焦虑持续存在的关联具有显著趋势(OR=1.32;95%CI,0.98-1.78),与抑郁障碍的持续存在具有显著关联(OR=1.49;95%CI,1.11-2.00)。短和长睡眠时间均与慢性病程轨迹独立相关(短睡眠:OR=1.50;95%CI,1.04-2.16;长睡眠:OR=2.91;95%CI,1.22-6.93)。
短时间和长时间睡眠都与慢性病程有关,这与症状严重程度无关。尚需确定治疗这些睡眠状况是否会带来抑郁和焦虑更有利的结局。